Spectrum Pharmaceuticals Alternatives & Competitors

12 companies similar to Spectrum Pharmaceuticals — Innovative solutions driving advancements in cancer treatment through strategic...

EOC Pharma Group

Empowering cancer care in China through a robust network of global partnerships, innovativ...

Series C $532.00M

Biopharma Biotechnology +3

OnQuality Pharmaceuticals Ltd.

developing innovative drugs and drug delivery systems that improve the quality of life of...

7 Series A $35.00M

Shanghai, China

Biopharma Biotechnology +3

Apollomics

We are a biopharmaceutical company committed to the discovery and development of mono- and...

26 Post-IPO Equity $262.60M

Foster City, United State...

Biotechnology Health Care +1

Xynomic Pharma

Focuses on in-licensing, developing and commercializing oncology drug candidates in China,...

12 Series B $4.80M

Dover, United States

Biopharma Biotechnology +1

Track all Spectrum Pharmaceuticals competitors

Get real-time alerts when any of these companies raise funding, hire, or show growth signals.

See how it works

Adlai Nortye

Pioneering the future of oncology with innovative drug development across the globe.

51-200 Post-IPO Equity $293.00M

Biotechnology Health Care +1

Genocea Biosciences

Pioneering innovative vaccines and immunotherapies for critical unmet medical needs using...

Post-IPO Equity $507.73M

Biotechnology Health Care

Thelial Technologies

Discovering and developing targeted carcinoma therapies through innovative drug discovery...

Grant $410.00K

Biotechnology Health Care +1

Hercules Pharmaceuticals

Driving Innovation in Non-Toxic Oral Therapies for Triple Negative Breast Cancer and Solid...

Seed $300.00K

Biopharma Biotechnology

Notable

Notable is a mission-driven company transforming the way cancer is treated

33 $71.35M

Foster City, United State...

Biotechnology Health Care

MethylGene

Harnessing Innovation to Develop Next-Generation Cancer Therapies

Venture round $71.83M

Biopharma Biotechnology

Synta Pharmaceuticals

Innovating patient care with advanced small molecule therapies for severe medical conditio...

Post-IPO Equity $217.35M

Biotechnology Health Care +1

Asieris Pharmaceuticals

We strive for healthy and dignified lives!

60 Series D $1.19B

United States

Biotechnology Health Care +1

About Spectrum Pharmaceuticals

Spectrum Pharmaceuticals is a biopharmaceutical company founded in 1987, with a focus on acquiring, developing, and commercializing innovative and targeted drug products within the field of oncology. The company's slogan emphasizes its commitment to driving advancements in cancer treatment through strategic development...

Business keywords

Biopharmaceutical Company, Oncology, Therapeutic Products, Drug Development, Clinical Development, Commercialization, Targeted Drug Products, Innovation, Acquisition, Licensing, Cancer Treatment, Strategic Development

Frequently Asked Questions

Companies similar to Spectrum Pharmaceuticals include EOC Pharma Group, OnQuality Pharmaceuticals Ltd., Apollomics, Xynomic Pharma, Adlai Nortye. They work in Biotechnology and Health Care and share Spectrum Pharmaceuticals's focus on oncology, drug development and cancer treatment.

Bounce Watch lists 12 companies that share Spectrum Pharmaceuticals's industries and are closest to it in business tags, services, target customers, business model and size.

Don't just read about them. Follow them.

BounceWatch watches Spectrum Pharmaceuticals and millions of other companies. When one raises money, hires quickly or changes its product, we tell you the same day.

See how it works

Explore Related

Spectrum Pharmaceuticals Profile EOC Pharma Group Alternatives OnQuality Pharmaceuticals Ltd. Alternatives Apollomics Alternatives All Companies All Signals Trend Reports

Compiled from the BounceWatch company index. We last looked at Spectrum Pharmaceuticals on 12 Sep 2024. The 12 companies listed here were last checked between 19 Jun 2024 and 8 Apr 2026. Where a field is blank here, it means we have not recorded it — not that the answer is zero. How we source and date this.